Reynolds RK - Search Results

1

Adherence to Hematologic Hold Parameters in Carboplatin and Dose-Dense Paclitaxel Chemotherapy for Ovarian Malignancies: A Survey of NCCN Member Institutions.

Stasenko M, Reynolds RK, Johnston C, Brackman M, McLean K, Uppal S. Stasenko M, et al. Among authors: reynolds rk. J Natl Compr Canc Netw. 2016 Jul;14(7):849-53. doi: 10.6004/jnccn.2016.0089. J Natl Compr Canc Netw. 2016. PMID: 27407125

2

Absence of cumulative bone marrow suppression in heavily pretreated ovarian cancer patients undergoing salvage chemotherapy with paclitaxel.

Pearl ML, Johnston CM, Reynolds RK, Roberts JA. Pearl ML, et al. Among authors: reynolds rk. Oncology. 1995 Sep-Oct;52(5):407-12. doi: 10.1159/000227498. Oncology. 1995. PMID: 7543668

3

Exponential regression of CA 125 during salvage treatment of ovarian cancer with taxol.

Pearl ML, Yashar CM, Johnston CM, Reynolds RK, Roberts JA. Pearl ML, et al. Among authors: reynolds rk. Gynecol Oncol. 1994 Jun;53(3):339-43. doi: 10.1006/gyno.1994.1144. Gynecol Oncol. 1994. PMID: 7911444 Free article. Clinical Trial.

4

Combined carboplatin and cisplatin. Limited prospects for dose intensification.

Waterhouse DM, Reynolds RK, Natale RB. Waterhouse DM, et al. Among authors: reynolds rk. Cancer. 1993 Jun 15;71(12):4060-6. doi: 10.1002/1097-0142(19930615)71:12<4060::aid-cncr2820711242>3.0.co;2-0. Cancer. 1993. PMID: 8508371 Review.

5

Treatment of refractory ovarian carcinoma with paclitaxel and cisplatin after treatment failure with single-agent paclitaxel.

Johnston CM, Pearl ML, Reynolds RK, Roberts JA, Morley GW. Johnston CM, et al. Among authors: reynolds rk. Eur J Gynaecol Oncol. 1995;16(6):439-47. Eur J Gynaecol Oncol. 1995. PMID: 8536758 Clinical Trial.

6

The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma.

Gretz HF3rd, Economos K, Husain A, Lesser M, Kaplan E, Caputo TA, Reynolds RK, Johnston CM, Pearl ML, Roberts JA. Gretz HF3rd, et al. Among authors: reynolds rk. Gynecol Oncol. 1996 Jun;61(3):409-15. doi: 10.1006/gyno.1996.0165. Gynecol Oncol. 1996. PMID: 8641624 Free article.

7

Vulvar melanoma: review of diagnosis, staging, and therapy.

Wechter ME, Reynolds RK, Haefner HK, Lowe L, Gruber SB, Schwartz JL, Johnston CM, Johnson TM. Wechter ME, et al. Among authors: reynolds rk. J Low Genit Tract Dis. 2004 Jan;8(1):58-69. doi: 10.1097/00128360-200401000-00012. J Low Genit Tract Dis. 2004. PMID: 15874838

8

Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer.

Pulaski HL, Spahlinger G, Silva IA, McLean K, Kueck AS, Reynolds RK, Coukos G, Conejo-Garcia JR, Buckanovich RJ. Pulaski HL, et al. Among authors: reynolds rk. J Transl Med. 2009 Jun 19;7:49. doi: 10.1186/1479-5876-7-49. J Transl Med. 2009. PMID: 19545375 Free PMC article.

9

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ. Silva IA, et al. Among authors: reynolds rk. Cancer Res. 2011 Jun 1;71(11):3991-4001. doi: 10.1158/0008-5472.CAN-10-3175. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498635 Free PMC article.

10

Metformin targets ovarian cancer stem cells in vitro and in vivo.

Shank JJ, Yang K, Ghannam J, Cabrera L, Johnston CJ, Reynolds RK, Buckanovich RJ. Shank JJ, et al. Among authors: reynolds rk. Gynecol Oncol. 2012 Nov;127(2):390-7. doi: 10.1016/j.ygyno.2012.07.115. Epub 2012 Aug 2. Gynecol Oncol. 2012. PMID: 22864111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page